Figure 2
IL-33 deficiency in the host nonhematopoietic cells decreases GVHD severity. (A) Survival of C57BL/6 mice (WT or IL-33 deficient) after TBI (1000 cGy) and transplantation of 8 × 105 T cells and 5 × 106 BM from BALB/c mice. Data pooled from 3 independent experiments. (B) Serum was taken from recipient mice on day 7 post–allo-HCT, and TNF-α production was measured by enzyme-linked immunosorbent assay (ELISA). Data from a single experiment.
